{"abstract": "Oracle said Friday that it had agreed to buy the drug data management software company Phase Forward for about $685 million in a deal aimed at bolstering its health sciences business.", "web_url": "https://dealbook.nytimes.com/2010/04/16/oracle-to-buy-phase-forward-for-685-million/", "snippet": "Oracle said Friday that it had agreed to buy the drug data management software company Phase Forward for about $685 million in a deal aimed at bolstering its health sciences business.", "lead_paragraph": "Oracle said Friday that it had agreed to buy the drug data management software company Phase Forward for about $685 million in a deal aimed at bolstering its health sciences business, Reuters reports.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Oracle to Buy Phase Forward for $685 Million", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "subject", "value": "Software", "rank": 2, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Boston Scientific Corporation", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Oracle Corp", "rank": 5, "major": "N"}], "pub_date": "2010-04-16T14:28:53+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/1dcd1a80-431b-5914-a211-a112ffbf3b16", "word_count": 126, "uri": "nyt://article/1dcd1a80-431b-5914-a211-a112ffbf3b16"}